Lumida
/AMPX
⌘K
Amprius Technologies Inc

Amprius Technologies Inc

AMPX
$10.16USD↑+0.59%+0.06 today

MARKET CAP

1.4B

P/E (TTM)

—

FWD P/E

575.8x

DAY RANGE

$9 – $10

52W RANGE

$6
$24

AI Summary

Stalk
TrimMedium

AMPX remains entrenched in a Stage 4 decline, marked by sequential lower highs and lower lows and a sustained downtrend below declining EMAs. Despite a Bearish Exhaustion signal and extreme oversold conditions hinting at seller fatigue, bearish execution is ill-timed. Defer selling (Trim) into relief rallies toward the descending EMA cluster and prior support turned resistance. The long-term uptrend above the 200-day SMA still holds unless decisively broken.

  • ↑Q1 2026 revenue $28.5M, +153% YoY and +13% sequential
  • ↑Firm $37.8M backlog and $14.8M DIU contract underpin $130M guidance
  • ↓Leverage risk elevated with high debt relative to earnings
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Amprius Technologies, Inc. (NASDAQ: AMPS) is a leader in the field of advanced silicon anode batteries, with applications spanning unmanned aerial systems (UAS), light electric vehicles, and military uses. The company’s innovative approach, particularly its proprietary silicon anode technology, positions it well within the growing market focused on energy density and efficiency. With increasing demand driven by defense spending and electric mobility, Amprius is emerging as a key player in the battery manufacturing landscape.

Bull says

  • ↑Q1 2026 revenue $28.5M, +153% YoY and +13% sequential
  • ↑Firm $37.8M backlog and $14.8M DIU contract underpin $130M guidance
  • ↑U.S. defense spending surge drives battery demand and market share
  • ↑Strong momentum and liquidity factors signal robust buying interest
  • ↑$62.4M cash balance provides runway for scaling production
  • ↑Analysts maintain Moderate Buy consensus, reflecting long-term confidence

Bear says

  • ↓Leverage risk elevated with high debt relative to earnings
  • ↓Negative earnings yield underscores potential profitability challenges
  • ↓Revenue concentration in defense contracts raises volatility risk
  • ↓Q1 gross margin fell to 20% from 24% amid legacy costs
  • ↓High short interest reflects investor skepticism
  • ↓Adjusted EBITDA loss of $1.8M signals ongoing cash-burn concerns

Investment themes with AMPX

Drones↓ -2.03%

Unmanned aerial vehicles and related technology

AVAV · ONDS · RCAT

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-10-2026neutral

Transcript signals

Bull points

  • we're pleased to report Q1 revenue of $28.5 million, up two and a half X year over year, and 13% higher sequentially.
  • The strong results give us the confidence to increase our revenue guidance for the full year to at least $130 million, five million above our previous forecast.
  • Quote, balancing the extreme discharge demands of actuation with the computational intensity of real-time AI processing requires a new generation of energy solutions.

Bear points

  • The asset impairment actually happened in Q4 of last year. You may have seen our DNA went down pretty meaningfully from well over a million dollars to only about 800K.
  • And so we should be out of the woods on Cymex.
  • Our Q1 gross profit was $5.7 million, producing a gross margin of 20%. For context, Q4 gross margin was 24%. So we did step back quarter over quarter, and I want to be transparent about why. Overhead costs associated with our Fremont facility are being absorbed across a larger cycle revenue base, while the Symax product line continues to wind down.
Read full transcript analysis ›